Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
51.56
-0.48 (-0.92%)
Nov 12, 2026, 4:00 PM EST - Market closed

Travere Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
123.5493.0458.5458.1861.69165.75
Short-Term Investments
348.28229.76312.17508.68388.56387.13
Cash & Short-Term Investments
471.82322.8370.7566.85450.25552.88
Cash Growth
85.37%-12.92%-34.60%25.90%-18.56%52.90%
Accounts Receivable
107.5380.1327.1221.1816.6515.91
Other Receivables
2.81.32.34.61.90.9
Receivables
110.3381.4329.4225.7818.5516.81
Inventory
10.525.886.29.414.527.31
Prepaid Expenses
40.7827.4610.3914.7410.135.82
Other Current Assets
----2.99-
Total Current Assets
633.45437.57416.7616.78486.44582.83
Property, Plant & Equipment
10.5314.619.6325.5430.0534.3
Goodwill
0.750.750.750.750.750.94
Other Intangible Assets
163.36113.12103.22103.6996.32147.5
Other Long-Term Assets
40.1439.1653.8242.1659.0311.07
Total Assets
848.23605.19594.13788.91672.59776.63

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
15.2824.823.5341.6817.2915.14
Accrued Expenses
187.22126.0486.03107.5795.7475.18
Current Portion of Long-Term Debt
--68.68---
Current Portion of Leases
6.315.885.414.914.433.91
Current Unearned Revenue
--2.827.111.9816.27
Other Current Liabilities
2.13.1914.2916.6612.7213.59
Total Current Liabilities
210.91159.9200.75177.91142.16124.09
Long-Term Debt
603.51311.72310.31377.26375.55226.58
Long-Term Leases
6.3311.1317.1922.6127.5131.5
Long-Term Unearned Revenue
---1.8410.9320.38
Other Long-Term Liabilities
4.897.66.88.4973.5971.98
Total Liabilities
825.65490.36535.05588.1629.73474.52

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
1,6221,5891,5061,3281,0601,069
Retained Earnings
-1,597-1,473-1,447-1,126-1,014-765.97
Comprehensive Income & Other
-2.05-1.19-0.08-1.46-2.91-0.56
Shareholders' Equity
22.58114.8359.08200.8142.85302.11
Total Liabilities & Equity
848.23605.19594.13788.91672.59776.63

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
616.16328.73401.58404.78407.49261.99
Net Cash (Debt)
-144.34-5.94-30.88162.0742.76290.9
Net Cash Growth
---279.04%-85.30%147.45%
Net Cash Per Share
-1.56-0.07-0.392.180.674.86
Filing Date Shares Outstanding
95.9992.2488.7476.164.7463.21
Total Common Shares Outstanding
95.6790.9287.4575.3764.2962.49
Working Capital
422.53277.66215.95438.87344.27458.74
Book Value Per Share
0.241.260.682.660.674.83
Tangible Book Value
-141.520.96-44.996.37-54.22153.68
Tangible Book Value Per Share
-1.480.01-0.511.28-0.842.46
Machinery
-5.134.725.064.994.73
Construction In Progress
---0.170.080.63
Leasehold Improvements
-8.999.379.699.188.79
SEC Filings: 10-K · 10-Q